New pain pill takes first step: safe in healthy volunteers?
NCT ID NCT06636500
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new drug called CG001419 in 72 healthy adults to see if it is safe and how the body processes it. The drug is being developed for pain relief. Participants took single or multiple doses, and some took it with food to check for effects. The study is complete, and results will guide future trials in people with pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER STUDY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Can patients safely dispense their own pain medicine after surgery?
- Parkinson's pain: could a new Add-On drug bring relief?
- Can pictures capture how chronic pain disrupts daily life?
- Could a simple choice sheet curb unneeded opioid prescriptions?
- Can a Pen-Like device make Kids' dental shots painless?